The importance of MCP-1 in glioma MDSC recruitment has recently been highlighted, where loss of CCR2, the MCP-1 receptor, demonstrated a reduction of MDSCs in the tumor and bone marrow of glioma bearing mice. Here, CCR2 is linked to central nervous system cancer.